Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
161M
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
35.2M
-
Shares change
-
-4.71M
-
Total reported value, excl. options
-
$85.1M
-
Value change
-
-$17.3M
-
Put/Call ratio
-
1.19
-
Number of buys
-
31
-
Number of sells
-
-79
-
Price
-
$2.42
Significant Holders of Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) as of Q2 2022
132 filings reported holding GRTS - Gritstone bio, Inc. - Common Stock, $0.0001 par value per share as of Q2 2022.
Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.2M shares
of 161M outstanding shares and own 21.9% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (6.95M shares), Frazier Life Sciences Management, L.P. (5.24M shares), Versant Venture Management, LLC (3.56M shares), VANGUARD GROUP INC (2.92M shares), Palo Alto Investors LP (2.33M shares), BlackRock Inc. (1.91M shares), Deep Track Capital, LP (1.72M shares), MORGAN STANLEY (1.29M shares), MILLENNIUM MANAGEMENT LLC (1.09M shares), and Assenagon Asset Management S.A. (991K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.